10X Genomics(TXG)
Focus: 10X Genomics is a public biotechnology platform company specializing in genomics and spatial biology technologies for research and diagnostics across oncology, neurology, and ophthalmology. The company operates as a technology enabler rather than a traditional drug developer, with $619M in FY2025 revenue.
Profile data last refreshed 24m ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
5
Should You Work at 10X Genomics?
AI assessment10X Genomics offers stability through platform-based recurring revenue but faces near-term headcount pressures; best suited for researchers willing to weather organizational restructuring in exchange for exposure to cutting-edge genomics technology.
Why Work Here
- Platform-driven business model with recurring revenue from instrument sales and consumables, reducing dependency on single-drug approvals
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$619M
Help build intelligence for 10X Genomics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.